Unlocking High-Viscosity Biologic Delivery With the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and Comprehensive Injection Modeling

As the biologics pipeline continues to evolve toward higher concentrations and viscosities, subcutaneous delivery faces increasing challenges in usability, balancing injection force and time, and optimizing patient experience. With biologics in development reaching significantly higher viscosities (30cP+), there is growing demand for advanced delivery solutions that exceed the capabilities of today’s standard. The BD Neopak™ XtraFlow™ Glass Prefillable Syringe portfolio, featuring ultra-thin wall 8mm needles, is engineered to reduce injection time and force, enabling delivery of high-viscosity drugs. Complementing this innovation, BD applies advanced injection science, including predictive modeling, tissue response analysis, and fluid dynamics simulations, to help our pharmaceutical partners derisk their delivery strategies and optimize combination design. This Learning Lab explores how this integrated approach, uniting platform innovation with deep scientific expertise, is supporting our pharmaceutical partners in pushing the boundaries of subcutaneous delivery and unlocking new possibilities for the next generation of biologics